From: Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells
Indication | Study type | Number of patients | Follow-up period | References |
---|---|---|---|---|
Soft tissue | Â | Â | Â | Â |
   Breast augmentation | Case reports | 403 | Up to 6 years | [9–11] (K Yoshimura, personal communication, University of Tokyo) |
   Craniofacial | Case reports | 58 | 9 to 13 months | [10, 21] (K Yoshimura, personal communication, University of Tokyo) |
   Irradiation fibrosis | Case reports | 20 | 31 months | [18] |
Orthopedic | Â | Â | Â | Â |
   Craniofacial | Case reports | 2 | >12 months | |
Immune | Â | Â | Â | Â |
   Crohn's disease | Phase I | 5 to 9 | 12 to 30 months | |
   Multiple sclerosis | Case reports | 3 | 7 months | [33] |